telos rx
Ranked #16 · Grade C
Four flat, posted price points across semaglutide and three tirzepatide formats, with a written promise the cost won't climb with your dose — a real step up in clarity from what we found last check — undercut by a state list it still won't publish.
- has an oral option if you would rather not inject
- scores 75/100 against Lean Meds's 38
SnagRx
Ranked #42 · Grade C
Compounded semaglutide at $69 a month and tirzepatide at $119, one flat price that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. Both figures are advertised against struck-through list prices of $299 and $399 under a live countdown clock, and the promise to lock that rate for life is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.
- $10/mo cheaper than Lean Meds
- scores 56/100 against Lean Meds's 38
Strut Health
Ranked #9 · Grade B−
Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.
- has an oral option if you would rather not inject
- scores 80/100 against Lean Meds's 38
ShedRx
Ranked #13 · Grade C
The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.
- offers FDA-approved brand pens, not just compounded
- has an oral option if you would rather not inject
- scores 76/100 against Lean Meds's 38
SynergyRX
Ranked #14 · Grade C
Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.
- offers FDA-approved brand pens, not just compounded
- has an oral option if you would rather not inject
- scores 76/100 against Lean Meds's 38
Shapely
Ranked #94 · Grade C
Shapely is the first provider in this batch that takes insurance — it says it is in network with Medicare and major PPO plans, and quotes brand-name co-pays of "typically $25 per month". That genuinely changes the arithmetic for anyone with coverage. What has to be read carefully is what the membership buys: $99 a month, $49 for the first, and it explicitly does not include medications or labs. So the compounded prices, $99 for semaglutide and $166 for tirzepatide, sit on top of the membership rather than replacing it.
- offers FDA-approved brand pens, not just compounded
- has an oral option if you would rather not inject
- scores 50/100 against Lean Meds's 38
yourEra
Ranked #15 · Grade C
A low-entry, all-in compounded program with both molecules and a clean cancel-anytime policy — appealing if the starting price holds, but the ongoing rate isn't published and the outcome claims are unverified marketing.
- scores 76/100 against Lean Meds's 38
BeyondMD
Ranked #69 · Grade C
BeyondMD publishes its prices before intake and names eleven clinicians with real bios, both of which are uncommon — but 'Starting at $125' is the floor of a $139-to-$449 band that appears on exactly one page, plus a $34 consultation fee and unpriced shipping, and the number you would actually pay is quoted on a phone call because every GLP-1 button leads to a lead form rather than a cart. Its Terms of Service contain no refund policy, no cancellation policy and no auto-renewal terms at all — the word 'refund' does not appear once in 44 KB.
- offers FDA-approved brand pens, not just compounded
- has an oral option if you would rather not inject
- scores 51/100 against Lean Meds's 38
Pepti
Ranked #33 · Grade C
Pepti publishes the lowest semaglutide price in this entire roster — $99 a month, flat at every titration dose, with the medication, physician review, shipping, refill management and unlimited messaging with your prescribing doctor all inside it. Tirzepatide is $199 on the same all-in, flat-at-every-dose basis. That number is low enough to deserve skepticism, so it is worth saying exactly where it comes from: Pepti states it on a dedicated cost page, repeats it in its FAQ ('we keep pricing flat and transparent at $99/mo all-in'), and prices the comparison against Hims, Henry Meds and Mochi on the same page. It names two prescribing physicians and says its medication is compounded by FDA-registered 503A or 503B pharmacies, though it never names which. The real limits are reach and format: it ships to 36 states rather than 50, it is cash-pay only and bills no insurance, and its needle-free oral GLP-1/GIP drops cost $349 — well above its own injection.
- has an oral option if you would rather not inject
- scores 58/100 against Lean Meds's 38